<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The benefit of preoperative chemotherapy in patients with initially resectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is still a matter of debate </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: We aim to evaluate the role of neoadjuvant chemotherapy on the outcome of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> undergoing potentially curative liver resection </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: One-hundred four patients were available for analysis </plain></SENT>
<SENT sid="3" pm="."><plain>Tested variables included age, sex, <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> TNM stage, location and grading, the number of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>, monolobar or bilobar location, interval time between <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> diagnosis and liver resection, Fong Clinical Risk Score (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>Neoadjuvant chemotherapy was administered according to the FOLFOX4 regimen </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Forty-four patients underwent liver resection without receiving neoadjuvant chemotherapy (group A); 60 patients received neoadjuvant chemotherapy (group B) </plain></SENT>
<SENT sid="6" pm="."><plain>At univariate analysis, only the time of liver resection seemed to affect overall survival: patients in group A showed a median survival time significantly superior to that of patients in group B (48 vs. 31 months; p=0.0358) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our findings suggest that, when feasible, resection of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> should be considered as an initial approach in this setting </plain></SENT>
<SENT sid="8" pm="."><plain>Further studies are needed to better delineate innovative therapeutic strategies that may lead to an improved outcome for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with surgically resectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>